Regulations.gov document
Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or…
Other · FDA-2019-D-0363 · posted Mar 13, 2019
Key facts
| Document ID | FDA-2019-D-0363-0002 |
|---|---|
| Title | Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections; Guidance for Industry; Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2019-D-0363 |
| Posted | Mar 13, 2019 |
| Comment period opens | Mar 13, 2019 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: